Clinical Diagnosis and Management of Complicated Folliculitis

Diagnostic Features and Clinical Presentation

The presence of central dusky coloration in lesions is particularly concerning and distinguishes furuncles from simple folliculitis, indicating deeper infection extending into the subcutaneous tissue, as noted by the Infectious Diseases Society of America 1, 2, 3
The clinical progression over a short period from initial folliculitis to multiple deeper, more painful lesions with dusky centers is classic for the evolution of furunculosis, according to the Infectious Diseases Society of America 1, 2, 3
Regional lymphadenitis, such as a tender inguinal lymph node, commonly occurs with skin infections in the drainage area and suggests bacterial etiology, particularly S. aureus, as indicated by the American Academy of Pediatrics 3, 4

The dusky central coloration warrants close monitoring for potential progression to necrotizing infection, and warning signs include rapidly expanding erythema, severe pain, systemic toxicity, crepitus, or bullae formation, as warned by the World Journal of Emergency Surgery 3, 5
For patients with multiple lesions, tender lymphadenopathy, and severe pain, systemic antibiotics are indicated along with incision and drainage of larger lesions, as recommended by the Infectious Diseases Society of America 2, 3

Larger furuncles require incision and drainage for source control, and thorough evacuation of pus and probing of the cavity to break up loculations are essential, as advised by the Infectious Diseases Society of America 2, 3
Systemic antibiotics are necessary for patients with multiple lesions, extensive surrounding symptoms, and lymphadenitis, with first-line oral therapy being doxycycline or minocycline, as recommended by the Infectious Diseases Society of America 2, 3, 6

Given the clear precipitating factor of pubic hair shaving, prevention counseling is critical, and measures include using proper lubrication when shaving, considering alternative hair removal methods, and avoiding manipulation of the skin, as suggested by the American Academy of Dermatology 6
If recurrent episodes develop, implementing a decolonization protocol, including intranasal mupirocin and daily chlorhexidine washes, can reduce recurrences, as recommended by the Infectious Diseases Society of America 2, 6

Furuncles extend deeper than simple folliculitis, reaching the dermis and subcutaneous tissue to form small abscesses, whereas folliculitis remains superficial with pus confined to the epidermis 7.
Clinically, a furuncle appears as an inflamed nodule with an overlying pustule through which a hair emerges; a dusky central coloration often signals the deeper infection 7.
Carbuncles consist of several adjacent follicles that coalesce into a larger inflammatory mass; pus drains from multiple follicular openings, most frequently on the posterior neck of patients with diabetes 7.
When evaluating a patient with nodular lesions, the presence of deeper nodules with dusky centers strongly suggests a furuncle rather than a superficial folliculitis 7.

Papulopustular eruptions are a common adverse effect of epidermal growth factor receptor (EGFR) inhibitors and mitogen‑activated protein kinase (MEK) inhibitors 8.
EGFR‑inhibitor–related rash occurs in 75 %–90 % of treated patients (all severity grades) and in 10 %–20 % of patients as grade 3/4 reactions, typically emerging within days to weeks after therapy starts 8.
The rash initially presents as follicular papules and pustules on the face (forehead, nose, cheeks) and may spread to the chest and upper back 8.
Patients frequently report associated pruritus, stinging, and pain 8.
Secondary bacterial colonization or superinfection is documented in up to 38 % of EGFR‑inhibitor rash cases 8.
MEK‑inhibitor–related rash develops in 74 %–85 % of patients (all grades) and in 5 %–10 % as grade 3/4 reactions; its clinical appearance mirrors that of EGFR‑inhibitor rash 8.
The recent initiation of EGFR or MEK inhibitor therapy (or other new medications such as antibiotics) should raise suspicion for a drug‑induced or fungal folliculitis‑like eruption 8.

Upper‑torso involvement (chest, back, upper trunk) favors Malassezia folliculitis; facial or sebaceous‑area lesions point toward drug‑induced eruptions; and deep nodules with dusky centers are indicative of furuncles [7][8].